These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 29575568)

  • 1. Association Between Serotonin Syndrome and Second-Generation Antipsychotics via Pharmacological Target-Adverse Event Analysis.
    Racz R; Soldatos TG; Jackson D; Burkhart K
    Clin Transl Sci; 2018 May; 11(3):322-329. PubMed ID: 29575568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of Off-Target Serotoninergic Drug Activity: An Analysis of Serotonin Syndrome Reports Using a Systematic Bioinformatics Approach.
    Culbertson VL; Rahman SE; Bosen GC; Caylor ML; Echevarria MM; Xu D
    Pharmacotherapy; 2018 Sep; 38(9):888-898. PubMed ID: 29972695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotics, glycemic disorders, and life-threatening diabetic events: a Bayesian data-mining analysis of the FDA adverse event reporting system (1968-2004).
    DuMouchel W; Fram D; Yang X; Mahmoud RA; Grogg AL; Engelhart L; Ramaswamy K
    Ann Clin Psychiatry; 2008; 20(1):21-31. PubMed ID: 18297583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin syndrome by drug interactions with linezolid: clues from pharmacovigilance-pharmacokinetic/pharmacodynamic analysis.
    Gatti M; Raschi E; De Ponti F
    Eur J Clin Pharmacol; 2021 Feb; 77(2):233-239. PubMed ID: 32901348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased 5-HT2cR and GHSR1a interaction in antipsychotic drug-induced obesity.
    Huang XF; Weston-Green K; Yu Y
    Obes Rev; 2018 Mar; 19(3):396-405. PubMed ID: 29119689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotics-associated serious adverse events in children: an analysis of the FAERS database.
    Kimura G; Kadoyama K; Brown JB; Nakamura T; Miki I; Nisiguchi K; Sakaeda T; Okuno Y
    Int J Med Sci; 2015; 12(2):135-40. PubMed ID: 25589889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative effect of lurasidone and blonanserin on cortical glutamate, dopamine, and acetylcholine efflux: role of relative serotonin (5-HT)2A and DA D2 antagonism and 5-HT1A partial agonism.
    Huang M; Panos JJ; Kwon S; Oyamada Y; Rajagopal L; Meltzer HY
    J Neurochem; 2014 Mar; 128(6):938-49. PubMed ID: 24164459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the Association of Hand-Foot Syndrome with Anticancer Drugs Using the US Food and Drug Administration Adverse Event Reporting System (FAERS) and Japanese Adverse Drug Event Report (JADER) Databases].
    Sasaoka S; Matsui T; Abe J; Umetsu R; Kato Y; Ueda N; Hane Y; Motooka Y; Hatahira H; Kinosada Y; Nakamura M
    Yakugaku Zasshi; 2016; 136(3):507-15. PubMed ID: 26935094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Disproportionality Analysis of the Adverse Drug Events Associated with Lurasidone in Paediatric Patients Using the US FDA Adverse Event Reporting System (FAERS).
    Rees KE; Chyou TY; Nishtala PS
    Drug Saf; 2020 Jun; 43(6):607-609. PubMed ID: 32248429
    [No Abstract]   [Full Text] [Related]  

  • 10. Data Mining FAERS to Analyze Molecular Targets of Drugs Highly Associated with Stevens-Johnson Syndrome.
    Burkhart KK; Abernethy D; Jackson D
    J Med Toxicol; 2015 Jun; 11(2):265-73. PubMed ID: 25876064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association Between Antipsychotics and Osteoporosis Based on Real-World Data.
    Yokoyama S; Wakamoto S; Tanaka Y; Nakagawa C; Hosomi K; Takada M
    Ann Pharmacother; 2020 Oct; 54(10):988-995. PubMed ID: 32186394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database.
    Christodoulos IN; Chyou TY; Nishtala PS
    Eur J Clin Pharmacol; 2020 Dec; 76(12):1775-1776. PubMed ID: 32719920
    [No Abstract]   [Full Text] [Related]  

  • 13. Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event database: a systematic Bayesian signal detection analysis.
    Baker RA; Pikalov A; Tran QV; Kremenets T; Arani RB; Doraiswamy PM
    Psychopharmacol Bull; 2009; 42(1):11-31. PubMed ID: 19204649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of action of brexpiprazole: comparison with aripiprazole.
    Stahl SM
    CNS Spectr; 2016 Feb; 21(1):1-6. PubMed ID: 26899451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hyponatremia Following Antipsychotic Treatment: In Silico Pharmacodynamics Analysis of Spontaneous Reports From the US Food and Drug Administration Adverse Event Reporting System Database and an Updated Systematic Review.
    Mazhar F; Battini V; Pozzi M; Invernizzi E; Mosini G; Gringeri M; Capuano A; Scavone C; Radice S; Clementi E; Carnovale C
    Int J Neuropsychopharmacol; 2021 Jul; 24(6):477-489. PubMed ID: 33575781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DRD2/ANKK1 Taq1A (rs 1800497 C>T) genotypes are associated with susceptibility to second generation antipsychotic-induced akathisia.
    Lawford BR; Barnes M; Swagell CD; Connor JP; Burton SC; Heslop K; Voisey J; Morris CP; Nyst P; Noble EP; Young RM
    J Psychopharmacol; 2013 Apr; 27(4):343-8. PubMed ID: 23118020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin syndrome after the use of tramadol and ziprasidone in a patient with a deep brain stimulator for Parkinson disease.
    El-Okdi NS; Lumbrezer D; Karanovic D; Ghose A; Assaly R
    Am J Ther; 2014; 21(4):e97-9. PubMed ID: 24158007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alleged isotretinoin-associated inflammatory bowel disease: disproportionate reporting by attorneys to the Food and Drug Administration Adverse Event Reporting System.
    Stobaugh DJ; Deepak P; Ehrenpreis ED
    J Am Acad Dermatol; 2013 Sep; 69(3):393-8. PubMed ID: 23683730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.
    Szarfman A; Tonning JM; Levine JG; Doraiswamy PM
    Pharmacotherapy; 2006 Jun; 26(6):748-58. PubMed ID: 16716128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
    Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
    Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.